Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Study objective is to determine whether Pioglitazone (PGZ) can improve clinical outcomes in
hyperglycemic acute ischemic stroke (IS). The rationale for the proposed research is to
develop an acute intervention that can improve neurological recovery and decrease mortality
and morbidity in high-risk diabetic stroke patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborator:
National Center for Advancing Translational Science (NCATS)